Loading
Accendra Health Inc/VA/ Stock: price and insider trades · United States
US·Mcap US$24.1M
No insider purchase over the last 90 days. The latest was filed 14 Aug 2025.
Accendra Health Inc/VA/: what insiders have been doing
This page follows insider dealings at Accendra Health Inc/VA/ as filed with SEC (Form 4) based in Mechanicsville, United States. The group dates from 1882. Over the twelve months to 18 October 2026, 15 filings were filed, from 7 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of Accendra Health Inc/VA/ has been absent for the past year. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction.
With 15 filings in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 10 purchases and 47 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 2.76 bn USD and net income of -1.10 bn USD.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
288
Thresholds
n/a
Buy Volume
€21M
10 ops. · all time
Sell Volume
€16M
47 ops. · all time
Who traded when
BuySaleColiseum Capital Management, LLC4 buys
Jonathan A. Leon1 sale
Analyst consensus: bullish or bearish?
Analysts rate Accendra Health Inc/VA/ Hold (neutral), based on 4 analysts. Average price target: US$1.26.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,582 of 24,148 companies
39.3
score / 100
Value59
Quality20
FCF yld·
Earn yld·
EV/EBITDA9.8x
ROE-198%
Gross mgn47%
Net mgn-40%
Debt/EBITDA9.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.31
Analyst consensus
4 analystsHold
US$0.50Target US$1.26(+304%)US$1.75
Income statement
RevenueUS$2.8B
Gross profitUS$1.3B47% margin
EBITDAUS$219.8M8% margin
Net income-US$1.1B-11.4% margin
Valuation
PER (forward)3.7x
Beta1.57
Balance sheet & cash
Market capUS$24.1M
Total debtUS$2.1B
Free Cash Flow-US$303.1M
Profitability & ownership
ROE-198.4%
ROA0.6%
% insiders8.0%
% institutions84.4%
Last declaration on 6 October 2026
Declarations288 total
283,554 shares0Common StockSEC:0000075252-26-000043:0
4,265 shares@ US$0.850.0064% mcap11.5% of flowCommon StockSEC:0000075252-26-000041:0
21,453,518 shares@ US$1.08100.0% of flowCommon StockSEC144:0001193125-26-389327
17,692 shares@ US$3.0430.9% of flowCommon StockSEC:0000075252-26-000035:0
7,908 shares@ US$3.0436.1% of flowCommon StockSEC:0000075252-26-000033:0
966 shares@ US$3.0413.3% of flowCommon StockSEC:0000075252-26-000034:0
1,770 shares@ US$3.0416.8% of flowCommon StockSEC:0000075252-26-000036:0
9,347 shares@ US$2.0386.7% of flowCommon StockSEC:0000075252-26-000013:0
20,841 shares@ US$2.0363.9% of flowCommon StockSEC:0000075252-26-000014:0
11,286 shares@ US$2.0371.7% of flowCommon StockSEC:0000075252-26-000015:0
58,945 shares@ US$2.0369.1% of flowCommon StockSEC:0000075252-26-000016:0
61,437 shares0Common StockSEC:0000075252-26-000006:0
85,067 shares0Common StockSEC:0000075252-26-000007:0
108,696 shares0Common StockSEC:0000075252-26-000008:0
47,908 shares0Common StockSEC:0000075252-25-000006:0
4,265 shares@ US$5.401.7% of flowCommon StockSEC:0000075252-25-000004:0
720,000 shares@ US$5.1515.2% of flowCommon Stock, par value $2 per share ("Common Stock")SEC:0000950170-25-109150:0
Canonical exit: 10 Nov 2025 (T+90)
5,764 shares@ US$6.35100.0% of flowCommon StockSEC:0001062993-25-011009:0
1,768 shares@ US$7.385.6% of flowCommon StockSEC:0001062993-25-009905:0
28,914 shares0Common StockSEC:0001062993-25-009729:0
28,914 shares0Common StockSEC:0001062993-25-009721:0
28,914 shares0Common StockSEC:0001062993-25-009726:0
28,914 shares0Common StockSEC:0001062993-25-009727:0
2,641 shares@ US$7.001.4% of flowCommon StockSEC:0001062993-25-009648:0
13,394 shares@ US$7.005.4% of flowCommon StockSEC:0001062993-25-009645:0
25 of 288 declarations
About Accendra Health Inc/VA/
ACCENDRA HEALTH INC is a Virginia-based company operating in the healthcare sector. It is listed on NASDAQ.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
